KINGWORLD (01110) released its annual performance with a net profit attributable to shareholders of 11.282 million yuan, a decrease of 72.9% year-on-year.
Golden Health Pharmaceutical Group (01110) released its annual performance for the year ending on December 31, 2025. The group achieved revenue of 917 million RMB during the period, a decrease of 13.5% year-on-year. The attributable net profit for the company's owners was 11.282 million RMB, a decrease of 72.9% year-on-year. Basic earnings per share were 1.92 cents.
KINGWORLD (01110) announced its annual performance for the year ending December 31, 2025. The group achieved a revenue of 917 million RMB, a decrease of 13.5% compared to the previous year. The net profit attributable to owners of the company was 11.282 million RMB, a decrease of 72.9%. The basic earnings per share was 1.92 cents.
Related Articles

CHANGHONG JH (03991) announced its annual performance with a net profit of approximately HK$401 million, representing a year-on-year increase of 5.69%.

ISP Global (08487): Yuan Shuangshun resigns as executive director and authorized representative.

VISION SYNERGY (00627) announced annual performance, with a net loss attributable to shareholders of 168 million yuan, a year-on-year decrease of 80.29%.
CHANGHONG JH (03991) announced its annual performance with a net profit of approximately HK$401 million, representing a year-on-year increase of 5.69%.

ISP Global (08487): Yuan Shuangshun resigns as executive director and authorized representative.

VISION SYNERGY (00627) announced annual performance, with a net loss attributable to shareholders of 168 million yuan, a year-on-year decrease of 80.29%.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


